Presented by
Management Forum
Cognitive Testing in Clinical Drug Trials: Successful Test Selection and Integration In-house Training
An an excellent opportunity to hear from a renowned cognition expert and gain a better understanding on the selection and successful integration of cognitive testing into therapeutic development programmes.
- Format: Live online
Course overview
Cognitive assessment has long been a key efficacy measure in clinical trials of indications such as Alzheimer’s disease. In the past few years, the use of cognitive efficacy measures has been extended to indications including Schizophrenia, Depression and Lewy body Dementias. The use of cognitive assessment has also been extended to the assessment of safety, especially in cardiology.
Cognitive assessment has been employed with variable success and a hallmark of failed examples has been the use of tests with poor reliability, validity and sensitivity. In this webinar we will review examples of both successful and failed case studies. We will conclude with recommendations for cognitive test selection and its successful integration into clinical drug trials.
This is an excellent opportunity to hear from a renowned cognition expert and gain a better understanding on the selection and successful integration of cognitive testing into therapeutic development programmes.
Browse our extensive selection of Life Sciences training courses for industry-leading insights into a range of topics. These include Medical Devices, IVDs, Biotech and Biopharma, Animal Health and Pharmaceutical training courses.
Benefits of attending
- Understand the increasing importance of cognitive testing in clinical drug trials
- Learn more about cognitive test selection and how to successfully integrate cognitive assessment in therapeutic development programmes
- Gain an opportunity to discuss the complexities of cognitive assessment with an expert in this field
Who should attend?
- Sponsor personnel responsible for cognitive test selection and integration
- CRO and site personnel involved in CNS clinical trials
- Industry analysts, regulators, journalists and anyone interested in discovering more about cognitive testing in clinical trials
This course will cover:
Programe
What is Cognition?
- A review of the various domains and their relevance to specific indications
What Makes a Good Cognitive Test?
- A review of issues: reliability, validity, and sensitivity
Case Studies:
- Measuring cognition in Alzheimer’s disease trials – a critical review
- Brintellix: successful development of cognitive labelling for an anti-depressant
- Evaluating safety in cardiology safety studies, the example of Valsartan
Recommendations and Points to Consider in Test Selection and Integration
Q & A and Discussion
John E. Harrison
Scottish Brain Sciences
Professor John Harrison is an acknowledged cognition expert whose principal professional interest is in helping people understand, maintain, and enhance their cognitive skills. He is Chief Scientific Officer at Scottish Brain Sciences where he advises on the selection and successful integration of cognitive testing into therapeutic development programs. John is an Associate Professor with the AUmc Alzheimer Center and Visiting Professor at King’s College London. He holds Chartered Psychologist status and has authored/co-authored more than 100 books and scientific articles, including a popular neuroscience book ‘Synaesthesia: The Strangest Thing’. John’s wider professional activities include conference hosting, professional voiceover acting and podcasting.
Social media links:
United States of America
- Pearson
